(Q37865009)

24 August 2017

1 reference

title

Cholangiocarcinoma--current treatment options (English)

1 reference

24 August 2017

0 references

S Friman

1

1 reference

24 August 2017

1 January 2011

1 reference

Scandinavian Journal of Surgery

24 August 2017

1 reference

24 August 2017

100

1 reference

24 August 2017

1

1 reference

24 August 2017

30-34

1 reference

Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States

24 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F145749691110000106

ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691110000106

Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691110000106

Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691110000106

Liver fluke-associated cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691110000106

Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691110000106

The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691110000106

Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691110000106

The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691110000106

Liver transplantation for malignant disease. Results in 93 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691110000106

Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691110000106

Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691110000106

Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691110000106

Review of gemcitabine in biliary tract carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691110000106

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691110000106

Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691110000106

Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691110000106

Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F145749691110000106

10.1177/145749691110000106

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21491796